New Insights on Glutathione's Supramolecular Arrangement and Its In Silico Analysis as an Angiotensin-Converting Enzyme Inhibitor

Molecules. 2022 Nov 17;27(22):7958. doi: 10.3390/molecules27227958.

Abstract

Angiotensin-converting enzyme (ACE) inhibitors are one of the most active classes for cardiovascular diseases and hypertension treatment. In this regard, developing active and non-toxic ACE inhibitors is still a continuous challenge. Furthermore, the literature survey shows that oxidative stress plays a significant role in the development of hypertension. Herein, glutathione's molecular structure and supramolecular arrangements are evaluated as a potential ACE inhibitor. The tripeptide molecular modeling by density functional theory, the electronic structure by the frontier molecular orbitals, and the molecular electrostatic potential map to understand the biochemical processes inside the cell were analyzed. The supramolecular arrangements were studied by Hirshfeld surfaces, quantum theory of atoms in molecules, and natural bond orbital analyses. They showed distinct patterns of intermolecular interactions in each polymorph, as well as distinct stabilizations of these. Additionally, the molecular docking study presented the interactions between the active site residues of the ACE and glutathione via seven hydrogen bonds. The pharmacophore design indicated that the hydrogen bond acceptors are necessary for the interaction of this ligand with the binding site. The results provide useful information for the development of GSH analogs with higher ACE inhibitor activity.

Keywords: DFT; M06-2X/6-311++G(d,p); angiotensin-converting enzyme; glutathione; molecular docking; supramolecular arrangement.

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors* / chemistry
  • Angiotensin-Converting Enzyme Inhibitors* / pharmacology
  • Binding Sites
  • Glutathione
  • Humans
  • Hypertension*
  • Molecular Docking Simulation

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Glutathione